Dr. Sha received her Bachelor’s degrees from UC Berkeley in Cognitive Science and Molecular Cell Biology, emphasizing in Neurobiology. She went on to obtain a Master’s degree in Physiology and MD from Georgetown University. She trained in Neurology at UCLA and Stanford University, and completed a clinical and research fellowship in Behavioral Neurology at UCSF, where she focused on identifying biomarkers for genetic forms of frontotemporal dementia and caring for patients with movement disorders and cognitive impairment.
While at UCSF, she saw the majority of patients with Huntington’s disease and ataxia in clinic and research, including ENROLL HD and the Natural History Study of and Genetic Modifiers in Spinocerebellar Ataxias. She has been a member of the Hungtington’s Study Group since 2011. She is board-certified in Neurology by the American Board of Psychiatry and Neurology and subspecialty boarded in Behavioral Neurology and Neuropsychiatry by the United Council for Neurologic Subspecialties.
Dr. Sha’s clinical expertise include Alzheimer’s disease, frontotemporal dementia, Lewy Body disease, corticobasal syndrome, progressive supranuclear palsy, Huntington’s disease, ataxia, multiple system atrophy, and other dementias.
Dr. Sha’s non-clinical time is spent conducting clinical trials in order to identify disease modifying treatments for dementia. She has a special interest in genetic forms of dementia and the cognitive impairment in Parkinsonian-related disorders.
Victoria Santini, MD
Dr. Santini received her Bachelor’s of Science in Chemistry at the University of Miami before traveling to Boston to complete a Master’s of Arts and her Medical Doctorate Degree at Boston University, School of Medicine. She continued her training there as a resident in Neurology, becoming chief resident in her final year, as well as her fellowship in Movement Disorders under Dr. Saint Hilaire.
Dr. Santini is a board-certified neurologist and Clinical Assistant Professor of Neurology at Stanford University, specializing in the diagnosis and management of movement disorders, including Parkinson’s disease and atypical parkinsonism, Huntington’s disease, dystonia, tic disorder, tremor, and ataxia. Dr. Santini also has a special interest in disorders of the autonomic nervous system and in Huntington’s Disease, which are the primary focuses of her research.
During her training, Dr. Santini followed approximately 100 patients with Huntington’s disease, where she gained expertise in all stages of disease from pre-symptomaticgenetic testing to later stages of the disease. Likewise, she followed many patients with various autonomic disorders, including multiple system atrophy and postural orthostatic tachycardia syndrome. She takes a holistic approach to patient care and hopes to integrate conservative and alternative therapies, where appropriate. She is also proficient in the use of DBS and Botox.